Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Neha Bansal, Steven E. Lipshultz, Emma R. Lipshultz(University of Miami), Sarju Ganatra(Lahey Medical Center), M. Jacob Adams, Sanjeev Aggarwal(Children's Hospital of Michigan), Steven D. Colan, Rudolf Steiner(University of Zurich), Shahnawaz Amdani(Cleveland Clinic)
Cited by 184
Related Papers
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
|Journal of the American Society of Echocardiography|2010|1.5k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
|New England Journal of Medicine|1991|1.2k
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589